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Abstract
We assessed sexual behaviors before and 12-months after ART initiation among 277
Mozambicans attending an HIV clinic. Measured behaviors included the number of sexual
partners, condom use, concurrent relationships, disclosure of HIV status, alcohol use, and
partners’ serostatus. Compared to before ART initiation, increases were seen 12 months after ART
in the proportion of participants who were sexually active (48% vs. 64% respondents, P < 0.001)
and the proportion of participants with HIV-negative or unknown serostatus partners (45% vs.
80%, P < 0.001). Almost all (96%) concurrent partnerships reported at 12 months formed after
ART initiation. Although reported correct and consist condom use increased, the number of
unprotected sexual relationships remained the same (n = 45). Non-disclosure of HIV-serostatus to
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sexual partners was the only significant predictor of practicing unprotected sex with partners of
HIV-negative or unknown serostatus. Sexual activity among HIV-positive persons on ART
increased 12 months after ART initiation. Ongoing secondary transmission prevention programs
addressing sexual activity with multiple partners, disclosure to partners and consistent condom use
with serodisconcordant partners must be incorporated throughout HIV care programs.
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Introduction
The expansion of antiretroviral therapy (ART) in low-income countries has improved the
health of HIV-positive individuals and their communities [1, 2] by reducing progression to
AIDS and death [3–5] and lowering infectivity by lowering viral load in plasma, semen, and
vaginal fluid [6, 7]. However, for every person initiating ART in resource-limited settings it
is estimated that there are four more newly-infected persons [8]. Individuals on ART feel
better and live longer with HIV, both of which increase the potential for more sexual activity
leading to secondary HIV transmission. A number of factors may influence secondary HIV
transmission risk, including health beliefs [9], HIV treatment optimism or complacency
(e.g., that non-detectable virus equates with inability to transmit HIV) [10, 11] or cultural
norms regarding gender-specific sexual behaviors. Other factors may include lack of
disclosure of HIV status, community stigma around HIV and alcohol and substance use that
may increase unsafe sexual practices.
Though some evidence from Uganda [12, 13] and North America [14, 15], and transmission
mathematical modeling [16, 17] show that increased ART coverage can reduce secondary
HIV transmission, it remains postulated that behavioral disinhibition [18] and insufficient
ART adherence [18] could erase the gains made by ART at the population level. In high-
income countries such as the United States (US), where HIV incidence plateaued for over a
decade, the number of new infections is estimated to have increased from 40,000 to 65,000
infections annually [19]. Increases in sexually transmitted infections (STIs) and sexual risk
behaviors have been seen among HIV-positive men who have sex with men [20–22]
including syphilis outbreaks in San Francisco [23]. Unprotected sex with discordant partners
is common in Africa, with its mature and generalized HIV epidemics. In Mozambique we
found that among individuals starting ART in 2004–2006, 65% of pre-ART sex acts were
unprotected and only 45% disclosed their HIV status to partners [24]. Similarly, several
studies from Africa have found an increase in high risk sexual behavior among persons
initiating ART [25, 26]. Other studies found no increase [27–29] or a decrease in high risk
sexual behavior 1 year after ART [12, 30, 31]. This study coupled with recent findings from
Africa regarding the association of ART and secondary HIV transmission risk [25–27, 30,
32] will help identify patterns of high risk sexual behavior and help guide prevention with
positive strategies. We therefore examined the sexual behaviors reported among 277 HIV-
positive Mozambican men and women in the 3 months prior to ART initiation, and 12
months later.
Methods
Participants and Setting
The study was conducted between October, 2004 and May, 2006 at the HIV care clinic in
the Beira Central Hospital, a large-volume public institution providing free specialized HIV
care and antiretroviral medications to all affected Mozambicans in Beira and the
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surrounding area. Clinic staff assessed patients’ ART eligibility based on standard
Mozambican norms for starting therapy (CD4 < 200/mm3 regardless of WHO stage, CD4
200–349/mm3 if in WHO stage 3 or pregnant, and WHO stage 4 regardless of CD4 count).
The staff pharmacist attempted to refer all persons initiating ART to the study team. The
research manager, in consultation with clinic staff, assessed the eligibility of potential
participants according to the following criteria: at least 18 years of age, living near the
clinic, and free of severe mental illness or dementia (as assessed by clinic staff). The study
protocol was reviewed and approved by the Institutional Review Boards of the Mozambique
Ministry of Health and the University of Washington. All participants provided written
consent (see [24]).
Procedures
During the study recruitment period, 683 people initiated ART, 433 were eligible for the
study, and 350 were enrolled on the day they started ART. As part of the primary study aim,
participants were randomly assigned to either a modified directly observed therapy
adherence intervention or standard care, and completed a 45-min interviewer–administered
questionnaire [33, 34]. As part of the secondary aim, which is reported in this paper,
participants reported their sexual behaviors during the 3 months prior to the day they
initiated ART and during the 3 months prior to the 12-month assessment point. Interviewers
attended a 5-day training and interviews were conducted in the local language. Participants
were reimbursed 25,000 meticais (approximately US$1) for each interview.
Measures
Most items and all scales were selected from published and validated measures and all items
were transcribed and pre-tested, and psychometric properties for validity and reliability were
assessed for cultural appropriateness in Beira, Mozambique [33].
Sexual Behavior—We asked respondents about the number of sexual partners 12 months
prior to and 12 months after initiating ART. At each assessment point, we assessed number
and type of sex acts (i.e., oral, anal, or vaginal) for each of the participants’ last three sexual
partners in the last 3 months, and the frequency of correct and consistent condom use (i.e.,
number of times condoms were used minus breakage, slippage, or incorrect application). To
assess concurrent relationships, participants provided the month, day, and year the
relationship began and ended. Any overlap in the last 12 month with two or more partners
was coded as a concurrent relationship. To validate this measure, participants were also
asked “About how many other sexual partners did you have during the time you were
together?” There were no discrepancies between the overlap dates and the response to this
single item question. If more than three partners were reported in the 3 month assessment
timeframe, summary questions were used to capture the number of partners, sex acts, and
condom use per sex act for the other partners. To calculate a correct and consistent score, we
set mechanical (not user-related) condom effectiveness at 0.95 to take into account product
defects and then adjusted this rate by the number of times a participant reported the condom
broke, slipped off, or was put on incorrectly in the prior 3 months. The ‘correct & consistent
condom use score’ ranged from 0 (poor or non use) to 0.95 (perfect and consistent use) [24].
Treatment Optimism (Complacency)—This measure is defined as “minimizing,
discounting, or discrediting the threat of HIV/AIDS” [11, p. 427]. Two sets of culturally
adapted measures assessed prevention-related attitudes and perceptions of ART medication.
Participants responded to 5 items on their attitudes about HIV/AIDS since ART treatment,
including HIV/AIDS being less of a threat, less worry about transmitting HIV, believing
there is now nearly a cure, HIV/AIDS is less serious than in the past, and being HIV-
positive is not a big problem now that treatment is available [10, 35, 36]. The standardized
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Cronbach’s α for this sample was 0.73. A second six-item scale captured whether
participants felt it was necessary to practice safer sex after initiating ART (α = 0.66).
Response to each item was made on a 4-point response scale ranging from strongly disagree
to strongly agree. A score for each scale was created. The summative score was divided by
the number of items over which the sum was calculated. Treatment optimism items were
added after the study began; thus only 201 participants responded.
To capture culturally appropriate social and cultural factors that may influence individuals’
perception and understanding of health risk, participants responded to 10 items about men’s
and women’s sexual roles in Mozambique society. Items asked the participants to rate the
validity of a statement in relation to both genders, such as, “a married man/woman can have
one or more sexual partner(s) than the person they are married to; a single man/woman can
have one or more sexual partners while dating another person; and men/women want more
sex than women/men”. Gender specific items included: “women having multiple male
partners is an economic necessity; there are more women than men so men are expected to
have multiple partners; and a man is obligated to have multiple partners.” Response options
were graded on a 4-point Likert scale ranging from “strongly disagree” to “strongly agree”
(α = 0.87).
A 21-item stigma scale, reduced from Berger et al. 40-item scale [37], captured the social
and emotional aspects of people living with HIV. This scale has been used in several studies
throughout southern and eastern Africa with good validity and reliability [38, 39]. The items
include social or public stigma (items relating to fear and rejection, such as what “most
people think about a person with HIV” or what “most people with HIV can expect when
others learn they have HIV”); negative self-image (items expressing “feelings of shame and
guilt such as feeling unclean, not as good as others, or like a bad person because of HIV”);
and personalized stigma (items relating to personal experiences or fears of rejection for
having HIV, such as “losing friends, feeling that people were avoiding him/her, and regrets
for having told some people”). Higher scores range from 21 to 84 with scores indicating
higher levels of stigma. The overall scale α = 0.90 for this population [37].
Soicodemographics—Variables such as gender, age, income, employment status, and
education were recorded at baseline; income and employment status were reassessed at 12
months after baseline via questionnaire.
Clinical Measures—Participants provided a 4–5 ml blood sample for a CD4 cell count as
part of standard care immediately prior to ART and 4 and 10 months after initiating ART.
The absolute CD4 cell count was determined through flow cytometry. A chart review was
conducted to record the CD4 test result closest to but within 2 months of the assessment
point. If a CD4 result was not available during this time frame, the participant was excluded
from this analysis (missing at 12 months n = 31).
Alcohol Use—If participants indicated alcohol or drugs use, they were asked a two-item
screening for alcohol and substance abuse. In the past 12 months… “did you drink alcohol
or used drugs more than you meant to” and “did you feel the need to cut down on your
drinking or drug use?” [40].
Sexual Partner Characteristics—For each of their last three sexual partners,
participants provided basic socio-demographic data, HIV status (status unknown or known
to have tested positive or negative), and approximate start and end dates to capture
concurrent relationships. Among those that were married, we assessed whether concurrent
relationships occurred outside the marriage, to account for legal polygamous marriages.
Pearson et al. Page 4
AIDS Behav. Author manuscript; available in PMC 2012 May 22.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Statistical Methods
We assessed change in sexual activity (sexual behavior, sexual partner characteristics) from
time 1 (3 months prior to ART initiation) and time 2 (3 months prior to the 12 month
assessment point) and factors (disclosure of HIV status, alcohol use, and socioeconomic
variables) associated with sexual behavior. To assess change in the baseline and the 12-
month measures, differences in continuous variables were tested using two-sided paired t
tests or Wilcoxon rank sum tests if the data were highly skewed. Associations between
categorical data variables were assessed using the McNemar test to compare proportions.
When assessing factors associated with sexual behavior 12 months after ART initiation, we
used the independent t test and Pearson chi-square as appropriate. We examined factors
associated with reported concurrent relationships and unprotected sex with partners whose
serostatus was HIV-negative or unknown (assessed as separate outcomes) by fitting a
logistic multivariable regression model including variables significant at the P = 0.05 level
in bivariate analyses. All analyses were conducted using two-sided tests and a significance
level of 0.05.
Results
Participants
At baseline, 350 HIV-positive persons starting ART were interviewed. At the 12 month
assessment point, 55 participants had died, and an additional 18 participants were lost to
follow-up. Of the remaining 277 participants included in these analyses, 100% reported only
heterosexual relationships, 7% any anal sex, and 8% any oral sex. Men were older than
women (Median 39: IQR 21, 45 compared to Mdn = 32, IQR = 27, 37, respectively:
difference 6.6 years, 95% confidence interval 4.7–8.4). Compared to the time of ART
initiation, more participants at 12 months after ART were employed (71% vs. 80%, χ2 =
11.7, P < 0.001) and had disclosed their HIV status to their sexual partner (58% vs. 73%, χ2
= 3.89, P < 0.001), and less reported substance use (36% vs. 21%, χ2 = 19.1, P < 0.001; see
Table 1).
Change in Sexual Activity from Time 1 to Time 2
Of the 277 participants (see Table 1), 48% (n = 133) reported sexual activity at time 1, while
64% (n = 177) reported sexual activity at time 2 (χ2 = 21.0, P < 0.001). Of these, 39% (n =
109) reported sexually active at both assessment points with no difference in the mean
number of partners (1.20 at baseline vs. 1.15 at 12 months). It is important to note that
although the mean is similar, the number of actual partners increased as 133 sexually active
participants at time 1 reported 157 partners while 12 months later 177 sexually active
participants reported 210 partners. Additionally, there was an increase in the number of
respondents whose partner’s HIV status was negative or unknown (45% vs. 80%, χ2 = 22.2,
P < 0.001). There was no difference in sexual activity between those randomized to
modified directly observed therapy or standard care.
As compared to time 1, at time 2, respondents reported higher correct and consistent
condom use (mean scores 0.36 vs. 0.77, t = 8.21, P < 0.001). The number of respondents
reporting unprotected sex with HIV-negative or unknown status person remained unchanged
(34%, n = 45 vs. 25%, n = 45, t = 1.71) with only five respondents reporting the same
behavior at time 1.
There was no significant difference in the proportion of participants who reported a
concurrent relationship in the 3 months prior to each assessment point (13% vs. 15%, χ2 =
1.98). However, there were more respondents reporting concurrent relationships (17–26) and
all but one respondent began a new concurrent relationship after ART initiation. Those who
Pearson et al. Page 5
AIDS Behav. Author manuscript; available in PMC 2012 May 22.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
reported concurrent relationships (vs. those who did not) also reported more unprotected sex
with their HIV-negative or unknown status partners at both time points (ART initiation:
70.6% vs. 29.2%, χ2 = 11.0, P < 0.001; 12-month assessment: 44.0%, vs. 22.5%, χ2 = 5.20,
P < 0.05, data not shown in table).
Correlates of High Risk Sexual Behavior 12 Months After ART
Twelve months after ART, there were several factors associated with being in a concurrent
relationship and practicing unprotected sex with a partner whose serostatus was HIV-
negative or unknown (Table 2). Having a concurrent relationship in the past 12 months was
associated with being male (77%, vs. 44%, χ2 = 9.80, P < 0.001), less likely to be living
with a partner (50% vs. 71%, χ2 = 4.11, P < 0.05), having unprotected sex (42% vs. 23%,
χ2 = 5.2, P < 0.01), less likely to disclose their HIV-serostatus (35% vs. 79%, χ2 = 22.3, P <
0.001), and belief that social and cultural factors encourages unsafe sex (27 vs. 24, t = 2.97,
P < 0.01).
Having unprotected sex (compared to protected sex) with a partner whose status was HIV
negative or unknown was associated with not living with a partner (53% vs. 72%, χ2 = 5.14,
P < 0.05), higher stigma scores (57 vs. 54, t = 2.42, P < 0.05), lower disclosure of HIV-
serostatus (51% vs. 79%, χ2 = 14.1, P < 0.001), and belief that social and cultural factors
encourages unsafe sex (26 vs. 24, t = 2.51, P < 0.05).
Few gender differences in HIV risk behavior and beliefs were found (data not shown in
tables). Specifically, men (as compared to women) were more likely to report a concurrent
relationship (16% vs. 4%, t = 3.77, P < 0.001), and had lower scores in perceiving HIV as a
threat since the availability of ART (18.6 vs. 19.2, t = 3.77, P < 0.01). There were no other
important gender differences at 12 months after ART initiation in other sexual behavior
variables.
Table 3 illustrates the results from the logistic regression analysis modeling significant
associations from the bivariate analysis. For both outcomes, respondents reporting a
concurrent relationship or unprotected sex with a partner who was HIV-negative or whose
HIV status was unknown were less likely to disclose their HIV status to their sexual partners
(OR = 0.07, SE 0.06, 95% CI = 0.01, 0.41; and OR = 0.32 SE 0.16, CI = 0.12, 0.83,
respectively).
Discussion
In this study we assessed change in sexual activity just prior to ART initiation and 12
months after ART initiation, and determined factors associated with changes in sexual
behavior. Overall, we found an increase in correct and consistent condom use. However,
there also was an increase in the proportion of participants having sex, the total number of
partners, and the number of partners with HIV-negative or unknown serostatus. Given that
an individual on ART has a lower viral load and thus a lower probability of transmitting
HIV to their partners (by 92% in one recent cohort study) [41–45], it is not clear as to
whether the changes in sexual activity in this population would lead to an increase in
secondary transmissions after ART initiation [16]. Mathematical modeling has projected a
slight reduction in annual HIV incidence and mortality to less than one case per 1,000
people within 10 years if all persons with HIV could be identified and treated with ART to
which they remained highly adherent [16]. However, more advanced modeling would be
required to investigate whether the increase in condom use coupled with ART-induced
lowered transmission risk—and factoring in ART adherence patterns—would outweigh the
increases in sexual activity in this population.
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Risk behaviors for the subset of participants who reported concurrent relationships warrant
concern. Notably, 96% of the concurrent relationships reported at the 12 month assessment
were newly formed, i.e., after initiating ART. While more men than women reported
concurrent sexual partnerships, almost half of all persons reporting concurrent sexual
partners also reported unprotected sex with their HIV-negative or unknown serostatus
partners, and a third were not disclosing their serostatus. This group (both men and women)
believed that social and cultural factors encourage men to have multiple sexual partners.
Finally, non-disclosure of serostatus was associated with concurrent relationships and
having unprotected sex with HIV-negative or unknown serostatus partner.
Though some have questioned its importance [46, 47], concurrency has been shown in
mathematical modeling [48] and in some observational studies [49] to propagate the
endemic spread of HIV in a population [50–52]. At the individual level, the partners of the
respondent who has concurrent relationships bear the increased HIV acquisition risk (i.e.,
one’s own concurrency is a risk for HIV transmission, not acquisition) [53]. The fact that the
HIV risk from concurrency is to the partners and not the already HIV-positive respondent
must guide appropriate counseling. Prevention with positives messaging to reduce
concurrency should focus on taking social and personal responsibility for preventing HIV
transmission [54, 55] in concern for partners’ and communities’ well-being, the fact that
HIV may still be transmitted even when on ART [56], and the self-protection value of
reducing the risk of reinfection with a resistant HIV strain or an STI that may harm the
person’s own health [57].
A limitation of this study was the potential of socially desirable responses and under-
reporting of sensitive items resulting from our reliance on self-reported behaviors and
interviewer–administered questionnaires. Low literacy rates prevent the use of self-
administered surveys. A preferred measure would be to adopt technologies (e.g., audio
computer-assisted assessments) that may reduce bias, and also lead to more complete data
particularly for sensitive questions [58]. Although these techniques do not completely ensure
accurate reporting, interviewer–administered surveys would tend to err on the side of
reporting fewer high risk behaviors resulting in an overly conservative representation. Since
the roll-out of ART in 2004, disclosure of HIV status may have become more socially
normalized in the past few years. However the continued persistence of HIV stigma even in
high-HIV prevalence communities suggests this may not be the case [59], and may remain a
serious impediment to more widespread PLWHA disclosure [60].
Conclusion
Unlike some other recent studies in sub-Saharan Africa [12, 27], we found evidence of
increased sexual risk behaviors among a minority of those who had been on ART for 1 year;
however, we cannot conclude that risk of secondary HIV transmission has changed. Indeed,
given increased condom use and the benefits of treatment on reducing infectivity and the
probability of transmission, secondary transmission risk may have decreased. Nonetheless,
our findings highlight the need to incorporate ongoing secondary prevention programs for
HIV-positive individuals into HIV care settings. Provider-delivered ‘positive prevention’
counseling has been shown in RCTs [61] and meta-analyses [62] in the US to work, and
might be effectively adapted for use in other cultural settings [63]. The need for such
counseling in high-burden sub-Saharan African settings has been repeatedly emphasized
[30, 64]. Since sexual behavior, relationships, and adaptation to HIV disease itself are
dynamic processes [65], periodic counseling that individualizes specific barriers, concerns,
beliefs and responsibility in regard to risk reduction would help reinforce behavior change
over time. Clinics may benefit from incorporating risk behavior screening at each visit to
identify those engaging in high-risk behavior and to support risk reduction strategies. For the
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subset of participants in this study who reported ongoing secondary HIV transmission risk,
some risk reduction messages may be more germane than others. This may include ‘loss-
framed’ messages [66] that emphasize the self-protection benefits of safer sex (e.g., to avoid
HIV reinfection or more commonly, other STIs that can increase viral load) [57]. There also
is suggestive evidence that unsafe sex is associated with nondisclosure [67–69] and ART
non-adherence [70], and conversely that disclosure can be associated with reduced sexual
transmission risk behaviors [71–73].
Secondly, perceived stigma, non-disclosure of serostatus to sexual partners, and the belief
that social cultural factors promote unsafe sexual practice (as has been noted elsewhere)
[74], call for a culturally appropriate social marketing campaign to help change community-
level beliefs and norms. For example, the message of “zero grazing” may have been a
powerful factor in reducing Uganda’s earlier HIV prevalence in the early 1990s [75].
Finally, correct and consistent condom use was seen in Uganda and provides encouraging
support that clinic-delivered support can have a beneficial impact. Effective prevention with
positive strategies must consider a combination of biomedical and behavioral interventions
that focus on the unique characteristics of specific populations.
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Table 1
Socio-economic, clinical, sexual behavior and complacency score characteristics of the 277 HIV-positive
participants at ART initiation and 12 months after ART initiation
ART initiation
N (%)
12 months after
ART initiation
N (%)
Test statistic
Socio-economic
   Living with spouse or partner 141 (51)  147 (53) χ2 = 1.29
   Currently employed 197 (71)  223 (80) χ2 = 11.7***
   Stigma (overall scale) 53.6 (10) 54.8 (7) t = 1.92
   Monthly income [U.S. Dollars, mean (SD)] 54 (78)    54 (74) t = 0.79
Clinical assessment
   Substance abuse (include alcohol) 101 (36)    58 (21) χ2 = 19.1***
   CD4 count [n = 220, mean (SD)] 130 (5)  307 (11) t = 15.6***
Sexual behaviora
   Sexually active 133 (48)  177 (64) χ2 = 21.0***
     Men (n = 121) 64 (53)    86 (71) χ2 = 11.0***
     Women (n = 156) 69 (44)    91 (58) χ2 = 10.0**
   Disclosed to sexual partner 76 (58)  128 (73) χ2 = 13.36***
   Total number of partners 157  210
     Sexually active at time 1 and time 2 –  109 (39%)
      Mean (SD) number of partners 1.20 (0.05) 1.15 (0.05) t = 0.39
     Reported a concurrent relationship 17 (13)    26 (15) χ2 = 1.98
     Total number of concurrent partners 37    55
     Mean (SD) number of concurrent partners 2.17 (0.52) 2.11 (0.32) t = 0.68
     Sexual partner HIV status is negative or unknown 60 (45)  142 (80) χ2 = 22.2***
     Unprotected sex: Partner HIV−/HIV? serostatus 45 (34)    45 (25) t = 1.71
     Correct and consistent condom score [mean (SD)] 0.36 (0.41) 0.77 (0.33) t = 8.21***
   Complacency scalesb [Mdn (IQR) range]
     HIV/AIDS less of a threat since ART –    24 (21,27) 16–35
     Social/cultural factors that encourages unsafe sex –    20 (18,20) 13–20
     Less need for safer sex since ART –    13 (13,14) 9–18
χ2, McNemar Chi2 (1 degree of freedom) for categorical data; t two-sided paired t test for continuous data; T1 number at ART Initiation, T2
number 12 months after ART Initiation, SD standard déviation
**P << 0.01;
***P < 0.001
a
Denominator for sexual behavior is reported for sexually active participants at each assessment point
bComplacency Scales were added after the baseline assessment and were available for 201 respondents
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Table 3
Summary of logistic regression analyses for variables predicting concurrent relationships and unprotected sex
with partners of HIV-negative or unknown serostatus 12 months after ART initiation
Odds ratio Standard error 95% CI
Reported a concurrent relationship
   Male   0.23 0.19 0.05, 1.18
   Living with spouse/partner   1.78 1.65 0.29, 11.00
   Disclosed to sexual partner   0.07 0.06 0.01, 0.41
   Unprotected sex with an HIV− or HIV? partner   2.69 2.28 0.51, 14.21
   Social/cultural factors that encourages unsafe sex   1.14 0.11 0.95, 1.37
   Wald χ2(5,124) 22.84***
Unprotected sex with an HIV−/HIV? partner
   Living with spouse/partner   0.78 0.38 0.30, 2.01
   Disclosed to sexual partner   0.32 0.16 0.12, 0.83
   Stigma   1.05 0.03 0.99, 1.11
   Social/cultural factors that encourages unsafe sex   1.12 0.08 0.98, 1.28
   Wald χ2(4, 124) 13.94**
HIV− HIV negative serostatus, HIV? HIV serostatus unknown
**P < 0.01;
***P < 0.001
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